Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer sells further shares in Sensodyne maker Haleon
Pfizer Sells $3.26B Stake in Haleon
Pfizer Inc. ($PFE) has sold its stake worth $3.26 billion in UK-based consumer healthcare company Haleon PLC ($GB:HLN). With this transaction,
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Pfizer sells stake in Sensodyne and Panadol maker Haleon worth around £2.4bn
Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6%
FiercePharma
23h
Pfizer gins up £2.4B after unloading hundreds of millions of Haleon shares
Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...
STAT
8d
Millions of Americans want to quit smoking. Critics say drugmakers and the FDA are failing them
There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...
Law
28d
Lawsuit Linking Zantac to Cancer Diagnoses Survives Fight Over Jurisdiction
GlaxoSmithKline
Holdings Inc.,
Pfizer
Inc., Sanofi-Aventis U.S. LLC, and Sanofi US Services Inc. as the defendants.
GlaxoSmithKline
,
Pfizer
and Sanofi argued in their motion to dismiss that ...
12d
Boehringer, GSK, Pfizer Still Face Zantac Cases Despite Mistrial
An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback